Polarean Imaging plc

Equities

POLX

GB00BF3DT583

Advanced Medical Equipment & Technology

Market Closed - London S.E. 11:35:06 2024-07-19 EDT 5-day change 1st Jan Change
1.7 GBX -1.45% Intraday chart for Polarean Imaging plc +7.94% -72.80%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Ingenta and Shearwater win deals AN
EARNINGS AND TRADING: Thruvision loss widens but Polarean loss narrows AN
Polarean Imaging plc Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Powerhouse resolves claim; PCI-PAL wins court case AN
Polarean Imaging Seeks $10 Million from Share Sale MT
Polarean Imaging to raise USD10 million via placing and subscription AN
Polarean Imaging Wins Order for Xenon MRI System in US MT
FTSE 100 hits record high on BoE vote, UK GDP AN
Polarean shares soar on University of Alabama deal for Xenon MRI AN
AIM WINNERS & LOSERS: Polarean wins deal; Genedrive completes placing AN
Polarean Imaging plc Receives Second De Novo Order for A New Xenon MRI System from the University of Alabama At Birmingham Hospital CI
Polarean Imaging wins order for new polariser AN
Polarean Imaging Wins Order for Hyperpolarization System in US MT
Polarean Imaging plc Receives Order for Upgraded Hyperpolariser CI
Nexteq confident of meeting full-year expectations AN
Polarean Imaging Secures New Patent for Hyperpolarized Imaging Platform MT
Polarean Imaging shares sink after announcing a costly strategic plan AN
Polarean Imaging strategic parter raises stake to above 10% AN
Nukem Isotopes Ups Polarean Imaging Stake MT
Polarean shares jump on Xenoview polariser order AN
AIM WINNERS & LOSERS: Smart Metering accepts offer; order for Polarean AN
Polarean Imaging Plc Receives First De Novo Order for A New XENOVIEWtm Polariser CI
Polarean Imaging Teams up with Vida Diagnostics on Magnetic Resonance Imaging Platform MT
Polarean Imaging partners with Vida Diagnostics on MRI solutions AN
Polarean Imaging plc Partnership with VIDA Diagnostics, Inc. to Streamline Adoption of Advanced MRI of the Lungs CI
Chart Polarean Imaging plc
More charts
Polarean Imaging PLC is a medical-imaging technology company, with an investigational drug-device combination product for magnetic resonance imaging (MRI). The Company and its subsidiary company operate as investigational drug-device combination companies operating in the high-resolution medical imaging research space. The Company develops equipment that enables existing MRI systems to achieve an improved level of pulmonary functional imaging and specializes in the use of hyperpolarized xenon gas (129Xe) as an imaging agent to visualize ventilation. 129Xe gas is being studied for visualization of gas exchange regionally in the smallest airways of the lungs, across the alveolar tissue membrane, and into the pulmonary bloodstream. The Company’s technology provides an investigational diagnostic approach, offering a non-invasive and radiation-free functional imaging platform. It operates in Canada, Germany, United Kingdom and United States. The Company’s subsidiary is Polarean, Inc.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.022 USD
Average target price
0.1021 USD
Spread / Average Target
+365.05%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. POLX Stock
  4. News Polarean Imaging plc
  5. Polarean Imaging Wins Order for Xenon MRI System in US